Allopregnanolone and Progesterone in Experimental Neuropathic Pain: Former and New Insights with a Translational Perspective

[1]  W. Maixner,et al.  Neuroinflammation and Central Sensitization in Chronic and Widespread Pain. , 2018, Anesthesiology.

[2]  Y. Yanagawa,et al.  NMDA Receptor Activation Underlies the Loss of Spinal Dorsal Horn Neurons and the Transition to Persistent Pain after Peripheral Nerve Injury , 2018, Cell reports.

[3]  J. Vela,et al.  Critical role of sigma-1 receptors in central neuropathic pain-related behaviours after mild spinal cord injury in mice , 2018, Scientific Reports.

[4]  E. Choleris,et al.  Steroids and the brain: 50years of research, conceptual shifts and the ascent of non-classical and membrane-initiated actions , 2018, Hormones and Behavior.

[5]  V. Kemmel,et al.  Evidence for effective structure‐based neuromodulatory effects of new analogues of neurosteroid allopregnanolone , 2018, Journal of neuroendocrinology.

[6]  M. Schumacher,et al.  Neurosteroidogenesis and progesterone anti‐inflammatory/neuroprotective effects , 2018, Journal of neuroendocrinology.

[7]  L. Garcia-Segura,et al.  Axonal transport in a peripheral diabetic neuropathy model: sex-dimorphic features , 2018, Biology of Sex Differences.

[8]  M. Tsuda.  Modulation of Pain and Itch by Spinal Glia , 2017, Neuroscience Bulletin.

[9]  M. Schumacher,et al.  Role of Sex Hormones on Brain Mitochondrial Function, with Special Reference to Aging and Neurodegenerative Diseases , 2017, Front. Aging Neurosci..

[10]  C. Hulsebosch,et al.  Neuronal-Glial Interactions Maintain Chronic Neuropathic Pain after Spinal Cord Injury , 2017, Neural plasticity.

[11]  M. Tsuda.  P2 receptors, microglial cytokines and chemokines, and neuropathic pain , 2017, Journal of neuroscience research.

[12]  Imane Lejri,et al.  Allopregnanolone and its analog BR 297 rescue neuronal cells from oxidative stress-induced death through bioenergetic improvement. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[13]  O. Taleb,et al.  Behavioral and electromyographic assessment of oxaliplatin-induced motor dysfunctions: Evidence for a therapeutic effect of allopregnanolone , 2017, Behavioural Brain Research.

[14]  R. Freeman,et al.  Neuropathic pain , 1999, The Lancet.

[15]  S. Maier,et al.  Nitroxidative Signaling Mechanisms in Pathological Pain , 2016, Trends in Neurosciences.

[16]  Mona Karout,et al.  Novel analogs of allopregnanolone show improved efficiency and specificity in neuroprotection and stimulation of proliferation , 2016, Journal of neurochemistry.

[17]  A. Beitz,et al.  Astrocyte sigma-1 receptors modulate connexin 43 expression leading to the induction of below-level mechanical allodynia in spinal cord injured mice , 2016, Neuropharmacology.

[18]  Y. Cui,et al.  Spinal mitochondrial-derived ROS contributes to remifentanil-induced postoperative hyperalgesia via modulating NMDA receptor in rats , 2016, Neuroscience Letters.

[19]  P. Micevych,et al.  Actions of Steroids: New Neurotransmitters , 2016, The Journal of Neuroscience.

[20]  A. Grimm,et al.  Alzheimer, mitochondria and gender , 2016, Neuroscience & Biobehavioral Reviews.

[21]  M. F. Coronel,et al.  Beyond reproduction: the role of progesterone in neuropathic pain after spinal cord injury , 2016, Neural regeneration research.

[22]  Natalia S. Adler,et al.  Temporal changes in the expression of the translocator protein TSPO and the steroidogenic enzyme 5α-reductase in the dorsal spinal cord of animals with neuropathic pain: Effects of progesterone administration , 2016, Neuroscience Letters.

[23]  Natalia S. Adler,et al.  Progesterone modulates pro-inflammatory cytokine expression profile after spinal cord injury: Implications for neuropathic pain , 2016, Journal of Neuroimmunology.

[24]  A. Walf,et al.  Neurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research , 2016, Journal of neuroendocrinology.

[25]  H. Vaudry,et al.  Comparative aspects of neurosteroidogenesis: From fish to mammals. , 2016, General and comparative endocrinology.

[26]  Blair H. Smith,et al.  Neuropathic pain: an updated grading system for research and clinical practice , 2016, Pain.

[27]  M. Schumacher,et al.  A functional progesterone receptor is required for immunomodulation, reduction of reactive gliosis and survival of oligodendrocyte precursors in the injured spinal cord , 2015, The Journal of Steroid Biochemistry and Molecular Biology.

[28]  L. Garcia-Segura,et al.  Neuroactive steroids and the peripheral nervous system: An update , 2015, Steroids.

[29]  M. Schumacher,et al.  Intranasal delivery of progesterone after transient ischemic stroke decreases mortality and provides neuroprotection , 2015, Neuropharmacology.

[30]  U. Lang,et al.  Sex hormone-related neurosteroids differentially rescue bioenergetic deficits induced by amyloid-β or hyperphosphorylated tau protein , 2015, Cellular and Molecular Life Sciences.

[31]  F. Salituro,et al.  Allopregnanolone Preclinical Acute Pharmacokinetic and Pharmacodynamic Studies to Predict Tolerability and Efficacy for Alzheimer’s Disease , 2015, PloS one.

[32]  A. M. Martinez,et al.  Neurotrauma and Inflammation: CNS and PNS Responses , 2015, Mediators of inflammation.

[33]  M. Schumacher,et al.  Progesterone and allopregnanolone in the central nervous system: Response to injury and implication for neuroprotection , 2015, The Journal of Steroid Biochemistry and Molecular Biology.

[34]  L. Arendt-Nielsen,et al.  Perspectives in Pain Research 2014: Neuroinflammation and glial cell activation: The cause of transition from acute to chronic pain? , 2015, Scandinavian journal of pain.

[35]  S. Flatters.  The contribution of mitochondria to sensory processing and pain. , 2015, Progress in molecular biology and translational science.

[36]  U. Lang,et al.  Improvement of neuronal bioenergetics by neurosteroids: implications for age-related neurodegenerative disorders. , 2014, Biochimica et Biophysica Acta.

[37]  T. Jensen,et al.  Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms , 2014, The Lancet Neurology.

[38]  W. Xia,et al.  Early repeated administration of progesterone improves the recovery of neuropathic pain and modulates spinal 18kDa-translocator protein (TSPO) expression , 2014, The Journal of Steroid Biochemistry and Molecular Biology.

[39]  E. Walters.  Neuroinflammatory contributions to pain after SCI: Roles for central glial mechanisms and nociceptor-mediated host defense , 2014, Experimental Neurology.

[40]  M. Marinovich,et al.  Perspectives on neuroinflammation and excitotoxicity: a neurotoxic conspiracy? , 2014, Neurotoxicology.

[41]  S. Esmaeili-Mahani,et al.  Allopregnanolone suppresses diabetes-induced neuropathic pain and motor deficit through inhibition of GABAA receptor down-regulation in the spinal cord of diabetic rats , 2014, Iranian journal of basic medical sciences.

[42]  LimaAnalía,et al.  Progesterone reduces secondary damage, preserves white matter, and improves locomotor outcome after spinal cord contusion. , 2014 .

[43]  A. Walf,et al.  Novel receptor targets for production and action of allopregnanolone in the central nervous system: a focus on pregnane xenobiotic receptor , 2014, Front. Cell. Neurosci..

[44]  M. F. Coronel,et al.  Progesterone reduces the expression of spinal cyclooxygenase‐2 and inducible nitric oxide synthase and prevents allodynia in a rat model of central neuropathic pain , 2014, European journal of pain.

[45]  O. Taleb,et al.  Potential role of allopregnanolone for a safe and effective therapy of neuropathic pain , 2014, Progress in Neurobiology.

[46]  M. Schumacher,et al.  Revisiting the roles of progesterone and allopregnanolone in the nervous system: Resurgence of the progesterone receptors , 2014, Progress in Neurobiology.

[47]  L. Garcia-Segura,et al.  Levels and actions of progesterone and its metabolites in the nervous system during physiological and pathological conditions , 2014, Progress in Neurobiology.

[48]  R. Brinton,et al.  Estrogen: A master regulator of bioenergetic systems in the brain and body , 2014, Frontiers in Neuroendocrinology.

[49]  M. Sofroniew,et al.  Reactive Gliosis and the Multicellular Response to CNS Damage and Disease , 2014, Neuron.

[50]  P. Thomas,et al.  Enhancement of cell surface expression and receptor functions of membrane progestin receptor α (mPRα) by progesterone receptor membrane component 1 (PGRMC1): evidence for a role of PGRMC1 as an adaptor protein for steroid receptors. , 2014, Endocrinology.

[51]  A. Lima,et al.  Progesterone reduces secondary damage, preserves white matter, and improves locomotor outcome after spinal cord contusion. , 2014, Journal of neurotrauma.

[52]  Maiken Nedergaard,et al.  Glia and pain: Is chronic pain a gliopathy? , 2013, PAIN®.

[53]  M. Schumacher,et al.  Therapeutic effects of progesterone in animal models of neurological disorders. , 2013, CNS & neurological disorders drug targets.

[54]  Ya-Yun Wang,et al.  Understanding the role of mitochondria in the pathogenesis of chronic pain , 2013, Postgraduate Medical Journal.

[55]  C. Hulsebosch,et al.  Reactive oxygen species contribute to neuropathic pain and locomotor dysfunction via activation of CamKII in remote segments following spinal cord contusion injury in rats , 2013, PAIN®.

[56]  A. Walf,et al.  Membrane progestin receptors in the midbrain ventral tegmental area are required for progesterone-facilitated lordosis of rats , 2013, Hormones and Behavior.

[57]  Ya-Yun Wang,et al.  Significant changes in mitochondrial distribution in different pain models of mice. , 2013, Mitochondrion.

[58]  S. Cuzzocrea,et al.  Spinal mitochondrial-derived peroxynitrite enhances neuroimmune activation during morphine hyperalgesia and antinociceptive tolerance , 2013, PAIN®.

[59]  R. Brinton.  Neurosteroids as regenerative agents in the brain: therapeutic implications , 2013, Nature Reviews Endocrinology.

[60]  H. Tozaki-Saitoh,et al.  Microglial regulation of neuropathic pain. , 2013, Journal of pharmacological sciences.

[61]  M. Schumacher,et al.  Distribution of membrane progesterone receptor alpha in the male mouse and rat brain and its regulation after traumatic brain injury , 2013, Neuroscience.

[62]  R. Pang,et al.  The Upregulation of Translocator Protein (18 kDa) Promotes Recovery from Neuropathic Pain in Rats , 2013, The Journal of Neuroscience.

[63]  M. E. Brocca,et al.  Progesterone down-regulates spinal cord inflammatory mediators and increases myelination in experimental autoimmune encephalomyelitis , 2012, Neuroscience.

[64]  J. Götz,et al.  Alzheimer's Disease, Oestrogen and Mitochondria: an Ambiguous Relationship , 2012, Molecular Neurobiology.

[65]  P. Thomas,et al.  Membrane Progesterone Receptors: Evidence for Neuroprotective, Neurosteroid Signaling and Neuroendocrine Functions in Neuronal Cells , 2012, Neuroendocrinology.

[66]  G. Bennett,et al.  Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin , 2012, PAIN.

[67]  D. Ahn,et al.  Progesterone produces antinociceptive and neuroprotective effects in rats with microinjected lysophosphatidic acid in the trigeminal nerve root , 2012, Molecular pain.

[68]  M. Schumacher,et al.  Progesterone Synthesis in the Nervous System: Implications for Myelination and Myelin Repair , 2011, Front. Neurosci..

[69]  Alec B. O’Connor.  Neuropathic Pain , 2012, PharmacoEconomics.

[70]  M. Schumacher,et al.  Experimental and clinical evidence for the protective role of progesterone in motoneuron degeneration and neuroinflammation , 2011, Hormone molecular biology and clinical investigation.

[71]  E. Kalso,et al.  A new definition of neuropathic pain , 2011, PAIN®.

[72]  S. King,et al.  Steroidogenic Acute Regulatory Protein Expression in the Central Nervous System , 2011, Front. Endocrin..

[73]  M. Schumacher,et al.  Progesterone attenuates astro- and microgliosis and enhances oligodendrocyte differentiation following spinal cord injury , 2011, Experimental Neurology.

[74]  P. Roig,et al.  Progesterone prevents nerve injury-induced allodynia and spinal NMDA receptor upregulation in rats. , 2011, Pain medicine.

[75]  J. Henry,et al.  Progesterone prevents development of neuropathic pain in a rat model: Timing and duration of treatment are critical , 2011, Journal of pain research.

[76]  A. Ahmadiani,et al.  Increase in formalin-induced tonic pain by 5alpha-reductase and aromatase inhibition in female rats , 2011, Pharmacology Biochemistry and Behavior.

[77]  O. Taleb,et al.  Allopregnanolone prevents and suppresses oxaliplatin-evoked painful neuropathy: Multi-parametric assessment and direct evidence , 2011, PAIN®.

[78]  M. F. Coronel,et al.  Progesterone prevents allodynia after experimental spinal cord injury. , 2011, The journal of pain : official journal of the American Pain Society.

[79]  M. di Luca,et al.  Distribution of interleukin-1 receptor complex at the synaptic membrane driven by interleukin-1β and NMDA stimulation , 2011, Journal of Neuroinflammation.

[80]  S. Cuzzocrea,et al.  Spinal NADPH oxidase is a source of superoxide in the development of morphine-induced hyperalgesia and antinociceptive tolerance , 2010, Neuroscience Letters.

[81]  B. McEwen,et al.  The role of corticosteroids and stress in chronic pain conditions. , 2010, Metabolism: clinical and experimental.

[82]  G. Cavaletti,et al.  Activation of the Liver X Receptor Increases Neuroactive Steroid Levels and Protects from Diabetes-Induced Peripheral Neuropathy , 2010, The Journal of Neuroscience.

[83]  A. Mensah-Nyagan,et al.  Progress in dorsal root ganglion neurosteroidogenic activity: Basic evidence and pathophysiological correlation , 2010, Progress in Neurobiology.

[84]  A. Mensah-Nyagan,et al.  Selective regulation of 3α-hydroxysteroid oxido-reductase expression in dorsal root ganglion neurons: A possible mechanism to cope with peripheral nerve injury-induced chronic pain , 2010, PAIN.

[85]  O. Taleb,et al.  Cellular and functional evidence for a protective action of neurosteroids against vincristine chemotherapy-induced painful neuropathy , 2010, Cellular and Molecular Life Sciences.

[86]  M. Schumacher,et al.  Membrane progesterone receptors localization in the mouse spinal cord , 2010, Neuroscience.

[87]  Rosero Velasco,et al.  Neuropatía inducida por quimioterapia: un problema no resuelto , 2010 .

[88]  J. Bruna,et al.  [Chemotherapy-induced peripheral neuropathy: an unresolved issue]. , 2010, Neurologia.

[89]  S. Pimlott,et al.  SSRI antidepressants do not confound single photon emission computed tomography (SPECT) imaging studies using the α4β2 nicotinic acetylcholine receptor [123I]5‐I‐A85380 ligand: In vivo and in vitro evidence , 2010, Synapse.

[90]  L. Garcia-Segura,et al.  Sex differences in neuroactive steroid levels in the nervous system of diabetic and non-diabetic rats , 2010, Hormones and Behavior.

[91]  A. Eckert,et al.  Sciatic nerve injury induces apoptosis of dorsal root ganglion satellite glial cells and selectively modifies neurosteroidogenesis in sensory neurons , 2010, Glia.

[92]  Doodipala Samba Reddy,et al.  Neurosteroids: endogenous role in the human brain and therapeutic potentials. , 2010, Progress in brain research.

[93]  K. Chung,et al.  Involvement of reactive oxygen species in long-term potentiation in the spinal cord dorsal horn. , 2010, Journal of neurophysiology.

[94]  A. Mensah-Nyagan,et al.  Evidence for a key role of steroids in the modulation of pain , 2009, Psychoneuroendocrinology.

[95]  David Julius,et al.  Cellular and Molecular Mechanisms of Pain , 2009, Cell.

[96]  James D Yager,et al.  Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications. , 2009, Biochimica et biophysica acta.

[97]  H. Vaudry,et al.  Neurosteroid biosynthesis: Enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides , 2009, Frontiers in Neuroendocrinology.

[98]  Michael Costigan,et al.  Neuropathic pain: a maladaptive response of the nervous system to damage. , 2009, Annual review of neuroscience.

[99]  M. Schumacher,et al.  Effects of progesterone on oligodendrocyte progenitors, oligodendrocyte transcription factors, and myelin proteins following spinal cord injury , 2009, Glia.

[100]  Shin-Da Lee,et al.  Neuroactive steroids inhibit spinal reflex potentiation by selectively enhancing specific spinal GABAA receptor subtypes , 2009, Pain.

[101]  J. Ochoa,et al.  NEUROPATHIC PAIN: REDEFINITION AND A GRADING SYSTEM FOR CLINICAL AND RESEARCH PURPOSES , 2009, Neurology.

[102]  D. Salvemini,et al.  Peroxynitrite: a strategic linchpin of opioid analgesic tolerance. , 2009, Trends in pharmacological sciences.

[103]  C. Hulsebosch,et al.  Mechanisms of chronic central neuropathic pain after spinal cord injury , 2009, Brain Research Reviews.

[104]  D. Stein,et al.  Direct inhibition of the mitochondrial permeability transition pore: A possible mechanism for better neuroprotective effects of allopregnanolone over progesterone , 2009, Brain Research.

[105]  G. Cavaletti,et al.  Docetaxel‐induced peripheral neuropathy: protective effects of dihydroprogesterone and progesterone in an experimental model , 2009, Journal of the peripheral nervous system : JPNS.

[106]  B. Bembi,et al.  Oxidative stress in NPC1 deficient cells: protective effect of allopregnanolone , 2008, Journal of cellular and molecular medicine.

[107]  M. Schumacher,et al.  Progesterone Effects on Neuronal Ultrastructure and Expression of Microtubule-associated Protein 2 (MAP2) in Rats with Acute Spinal Cord Injury , 2009, Cellular and Molecular Neurobiology.

[108]  H. Kim,et al.  Increased production of mitochondrial superoxide in the spinal cord induces pain behaviors in mice: The effect of mitochondrial electron transport complex inhibitors , 2008, Neuroscience Letters.

[109]  M. Schumacher,et al.  Progesterone and progestins: neuroprotection and myelin repair. , 2008, Current opinion in pharmacology.

[110]  P. Dash,et al.  Nonclassical mechanisms of progesterone action in the brain: I. Protein kinase C activation in the hypothalamus of female rats. , 2008, Endocrinology.

[111]  J. Peluso,et al.  Progesterone receptor membrane component 1—Many tasks for a versatile protein , 2008, Steroids.

[112]  D. Edwards,et al.  The role and mechanism of progesterone receptor activation of extra-nuclear signaling pathways in regulating gene transcription and cell cycle progression , 2008, Steroids.

[113]  E. Schwartz,et al.  Oxidative stress in the spinal cord is an important contributor in capsaicin-induced mechanical secondary hyperalgesia in mice , 2008, PAIN.

[114]  D. Caruso,et al.  Neuroprotective Effects of Dihydroprogesterone and Progesterone in an Experimental Model of Nerve Crush Injury , 2022 .

[115]  G. Perkins,et al.  Mitochondrial fragmentation in neurodegeneration , 2008, Nature Reviews Neuroscience.

[116]  P. Thomas.  Characteristics of membrane progestin receptor alpha (mPRα) and progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating rapid progestin actions , 2008, Frontiers in Neuroendocrinology.

[117]  Richard F. Thompson,et al.  Progesterone receptors: Form and function in brain , 2008, Frontiers in Neuroendocrinology.

[118]  J. Dostrovsky,et al.  Neuropathic pain , 2008, Neurology.

[119]  A. Mensah-Nyagan,et al.  Endogenous steroid production in the spinal cord and potential involvement in neuropathic pain modulation , 2008, The Journal of Steroid Biochemistry and Molecular Biology.

[120]  A. Mensah-Nyagan,et al.  The biological activity of 3α-hydroxysteroid oxido-reductase in the spinal cord regulates thermal and mechanical pain thresholds after sciatic nerve injury , 2008, Neurobiology of Disease.

[121]  G. Panzica,et al.  The endocrine nervous system: Source and target for neuroactive steroids , 2008, Brain Research Reviews.

[122]  M. Schumacher,et al.  The membrane-associated progesterone-binding protein 25-Dx: Expression, cellular localization and up-regulation after brain and spinal cord injuries , 2008, Brain Research Reviews.

[123]  G. Cavaletti,et al.  Neuroactive steroids and peripheral neuropathy , 2008, Brain Research Reviews.

[124]  A. Mensah-Nyagan,et al.  Biochemical and functional evidence for the control of pain mechanisms by dehydroepiandrosterone endogenously synthesized in the spinal cord , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[125]  J. H. Kim,et al.  The role of reactive oxygen species in capsaicin-induced mechanical hyperalgesia and in the activities of dorsal horn neurons , 2007, PAIN®.

[126]  S. Cuzzocrea,et al.  Therapeutic manipulation of peroxynitrite attenuates the development of opiate-induced antinociceptive tolerance in mice. , 2007, The Journal of clinical investigation.

[127]  K. Chung,et al.  Reactive oxygen species (ROS) are involved in enhancement of NMDA-receptor phosphorylation in animal models of pain , 2007, PAIN.

[128]  L. Gentet,et al.  GABAA and glycine receptor‐mediated transmission in rat lamina II neurones: relevance to the analgesic actions of neuroactive steroids , 2007, The Journal of physiology.

[129]  Clifford J. Woolf,et al.  Nociceptors—Noxious Stimulus Detectors , 2007, Neuron.

[130]  G. Cavaletti,et al.  Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: A multimodal analysis , 2007, Neuroscience.

[131]  M. Ballabio,et al.  Neuroactive steroids , 2007, Journal of Molecular Neuroscience.

[132]  A. Mensah-Nyagan,et al.  Neurogenic pain and steroid synthesis in the spinal cord , 2007, Journal of Molecular Neuroscience.

[133]  C. Chinopoulos,et al.  Bioenergetics and the formation of mitochondrial reactive oxygen species. , 2006, Trends in pharmacological sciences.

[134]  Alastair M. Hosie,et al.  Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites , 2006, Nature.

[135]  L. Garcia-Segura,et al.  Steroids and glial cell function , 2006, Glia.

[136]  M. Beal,et al.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.

[137]  D. Nutt,et al.  Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. , 2006, Trends in pharmacological sciences.

[138]  J. Espallergues,et al.  Neuro(active)steroids actions at the neuromodulatory sigma1 (σ1) receptor: Biochemical and physiological evidences, consequences in neuroprotection , 2006, Pharmacology Biochemistry and Behavior.

[139]  D. Stein.  Progesterone in the experimental treatment of central and peripheral nervous system injuries , 2006 .

[140]  L. Garcia-Segura,et al.  Neuroactive steroids prevent peripheral myelin alterations induced by diabetes , 2006, Neuroscience Letters.

[141]  B. Meyerson,et al.  Spinal NMDA receptor phosphorylation correlates with the presence of neuropathic signs following peripheral nerve injury in the rat , 2006, Neuroscience Letters.

[142]  G. Cruccu,et al.  Pathophysiological mechanisms of neuropathic pain , 2006, Neurological Sciences.

[143]  M. Schumacher,et al.  Injury elicited increase in spinal cord neurosteroid content analyzed by gas chromatography mass spectrometry. , 2006, Endocrinology.

[144]  L. Garcia-Segura,et al.  Steroidogenic acute regulatory protein in the brain , 2006, Neuroscience.

[145]  K. Chung,et al.  Levels of mitochondrial reactive oxygen species increase in rat neuropathic spinal dorsal horn neurons , 2006, Neuroscience Letters.

[146]  A. Mensah-Nyagan,et al.  Effect of streptozotocin-induced diabetes on the gene expression and biological activity of 3β-hydroxysteroid dehydrogenase in the rat spinal cord , 2005, Neuroscience.

[147]  M. Barrot,et al.  Inflammatory Pain Upregulates Spinal Inhibition via Endogenous Neurosteroid Production , 2005, The Journal of Neuroscience.

[148]  P. Ježek,et al.  Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. , 2005, The international journal of biochemistry & cell biology.

[149]  Shuxing Wang,et al.  Molecular Expression of Spinal NMDA Receptor and PKC after Chronic Morphine Is Regulated by Spinal Glucocorticoid Receptor , 2005 .

[150]  V. Jevtovic-Todorovic,et al.  5α-reduced neuroactive steroids alleviate thermal and mechanical hyperalgesia in rats with neuropathic pain , 2005, Pain.

[151]  J. Lambert,et al.  Neurosteroids: endogenous regulators of the GABAA receptor , 2005, Nature Reviews Neuroscience.

[152]  K. Chung,et al.  Enhancement of NMDA receptor phosphorylation of the spinal dorsal horn and nucleus gracilis neurons in neuropathic rats , 2005, Pain.

[153]  A. Mensah-Nyagan,et al.  Substance P inhibits progesterone conversion to neuroactive metabolites in spinal sensory circuit: a potential component of nociception. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[154]  M. Schumacher,et al.  The membrane‐associated progesterone‐binding protein 25‐Dx is expressed in brain regions involved in water homeostasis and is up‐regulated after traumatic brain injury , 2005, Journal of neurochemistry.

[155]  M. Baba,et al.  Upregulation of mRNAs coding for AMPA and NMDA receptor subunits and metabotropic glutamate receptors in the dorsal horn of the spinal cord in a rat model of diabetes mellitus. , 2005, Brain research. Molecular brain research.

[156]  C. Zorumski,et al.  New evidence that both T-type calcium channels and GABAA channels are responsible for the potent peripheral analgesic effects of 5α-reduced neuroactive steroids , 2005, Pain.

[157]  M. Schumacher,et al.  Progesterone up-regulates neuronal brain-derived neurotrophic factor expression in the injured spinal cord , 2004, Neuroscience.

[158]  T. Penning,et al.  Anatomical and cellular localization of neuroactive 5α/3α‐reduced steroid‐synthesizing enzymes in the spinal cord , 2004 .

[159]  R. Coggeshall,et al.  Reactive oxygen species (ROS) play an important role in a rat model of neuropathic pain , 2004, Pain.

[160]  S. Li,et al.  Impact of neuropathic pain on the gene expression and activity of cytochrome P450side-chain-cleavage in sensory neural networks , 2004, Cellular and Molecular Life Sciences CMLS.

[161]  T. Penning,et al.  Anatomical and cellular localization of neuroactive 5 alpha/3 alpha-reduced steroid-synthesizing enzymes in the spinal cord. , 2004, The Journal of comparative neurology.

[162]  B. Stoffel‐Wagner.  Neurosteroid Biosynthesis in the Human Brain and Its Clinical Implications , 2003, Annals of the New York Academy of Sciences.

[163]  J. Turrens,et al.  Mitochondrial formation of reactive oxygen species , 2003, The Journal of physiology.

[164]  C. King,et al.  N-Methyl-d-aspartate receptor subunit expression and phosphorylation following excitotoxic spinal cord injury in rats , 2003, Neuroscience Letters.

[165]  K. Tsutsui,et al.  Cellular distribution and bioactivity of the key steroidogenic enzyme, cytochrome P450side chain cleavage, in sensory neural pathways , 2003, Journal of neurochemistry.

[166]  Roberta Diaz Brinton,et al.  Mechanism of estrogen-mediated neuroprotection: Regulation of mitochondrial calcium and Bcl-2 expression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[167]  D. Lamb,et al.  An Essential Component in Steroid Synthesis, the Steroidogenic Acute Regulatory Protein, Is Expressed in Discrete Regions of the Brain , 2002, The Journal of Neuroscience.

[168]  M. Schumacher,et al.  3β-Hydroxysteroid dehydrogenase expression in rat spinal cord , 2002, Neuroscience.

[169]  M. Millan.  Descending control of pain , 2002, Progress in Neurobiology.

[170]  S. Kato,et al.  Transcriptional regulation of the mouse steroid 5alpha-reductase type II gene by progesterone in brain. , 2002, Nucleic acids research.

[171]  M. Schumacher,et al.  3 Beta-hydroxysteroid dehydrogenase expression in rat spinal cord. , 2002, Neuroscience.

[172]  T. Jensen,et al.  The clinical picture of neuropathic pain. , 2001, European journal of pharmacology.

[173]  A. Basbaum,et al.  Molecular mechanisms of nociception , 2001, Nature.

[174]  A. Basbaum,et al.  PKCγ Contributes to a Subset of the NMDA-Dependent Spinal Circuits That Underlie Injury-Induced Persistent Pain , 2001, The Journal of Neuroscience.

[175]  I. Scheffler,et al.  A century of mitochondrial research: achievements and perspectives. , 2001, Mitochondrion.

[176]  M. Bennett,et al.  Protein kinase C modulates NMDA receptor trafficking and gating , 2001, Nature Neuroscience.

[177]  E. Baulieu.  [Neurosteroids, their role in brain physiology: neurotrophicity, memory, aging...]. , 2001, Bulletin de l'Academie nationale de medecine.

[178]  C. Goodchild,et al.  Antinociceptive properties of neurosteroids I. Spinally-mediated antinociceptive effects of water-soluble aminosteroids , 2000, Pain.

[179]  C. Goodchild,et al.  Antinociceptive properties of neurosteroids II. Experiments with Saffan® and its components alphaxalone and alphadolone to reveal separation of anaesthetic and antinociceptive effects and the involvement of spinal cord GABAA receptors , 2000, Pain.

[180]  J. Wrathall,et al.  Changes in NMDA Receptor Subunit Expression in Response to Contusive Spinal Cord Injury , 2000, Journal of neurochemistry.

[181]  R. Dubner,et al.  Progesterone attenuates persistent inflammatory hyperalgesia in female rats: involvement of spinal NMDA receptor mechanisms , 2000, Brain Research.

[182]  E. Baulieu.  Neuroactive neurosteroids: dehydroepiandrosterone (DHEA) and DHEA sulphate , 1999, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[183]  M. Chopp,et al.  Progesterone is neuroprotective after acute experimental spinal cord trauma in rats. , 1999, Spine.

[184]  H. Vaudry,et al.  Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system. , 1999, Pharmacological reviews.

[185]  M. Feuilloley,et al.  In Vivo and In Vitro Evidence for the Biosynthesis of Testosterone in the Telencephalon of the Female Frog , 1996, Journal of neurochemistry.

[186]  M. Feuilloley,et al.  Localization of 17beta-hydroxysteroid dehydrogenase and characterization of testosterone in the brain of the male frog. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[187]  E. Baulieu,et al.  Neurosteroids Biosynthesis and function , 1994, Trends in Endocrinology & Metabolism.

[188]  S. Paul.  NEUROACTIVE STEROIDS , 1992, Pediatric Research.

[189]  D Bertrand,et al.  Progesterone modulates a neuronal nicotinic acetylcholine receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[190]  B. O’Malley,et al.  Molecular mechanism of action of a steroid hormone receptor. , 1991, Recent progress in hormone research.

[191]  E. Baulieu,et al.  Neurosteroids: A new brain function? , 1990, The Journal of Steroid Biochemistry and Molecular Biology.

[192]  E. Baulieu,et al.  Pregnenolone and its sulfate ester in the rat brain , 1983, Brain Research.

[193]  E. Baulieu,et al.  Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. , 1981, Proceedings of the National Academy of Sciences of the United States of America.